Heather Bresch started out as a clerk at Mylan Pharmaceuticals in 1992. After lying on her resume about obtaining an MBA, she eventually worked her way up and became the Chief Executive Officer in 2012. Shortly after becoming the CEO, she aggressively increased the price of Mylan’s EpiPen. The news exploded. The average cost rose from about $100 to over $600! She blamed insurance companies for the
The content, material and statements provided on this site are for informational purposes only. Such content, material and statements are not intended as a substitute for professional medical advice, diagnosis or treatment. Your accessing this site does not create a physician/patient relationship between you and Dan Diamond. Always seek the advice of your third-party physician or other qualified health provider regarding any medical condition you have or that may hereafter arise. Neither NogginStorm, LLC nor Dan Diamond recommend or endorse any specific tests, physicians, products, procedures, opinions or other like information that may be mentioned on this site. Your acting in contradiction to the above understandings is solely at your own risk.